News

Arjuna to feature Shoden at Hi Europe

22 Oct 2018

At Hi Europe 2018 (27-29 November, Frankfurt) Arjuna Natural will feature Shoden, which it describes as a potent, all-natural, bioactivity confirmed extract of ashwagandha (Withania somnifera).

At Hi Europe 2018 (27-29 November, Frankfurt) Arjuna Natural will feature Shoden, which it describes as a potent, all-natural, bioactivity confirmed extract of ashwagandha (Withania somnifera). Shoden contains ashwagandha extract standardised with 35% withanolide glycosides, a highly active component of ashwagandha. Shoden is manufactured from carefully selected shwagandha roots and leaves. Toxins are removed from the roots and leaves using a proprietary detoxification process that also removes other undesirable components and maintains withanolide glycosides at optimum levels.

Arjuna says it developed its Bioactive Ingredient Protection System (BIPS) proprietary safety technology to ensure optimal delivery of the bioactive components of ashwagandha. BIPS is a patented procedure in which all the active molecules are encapsulated in a shield to deliver them safely and at the desired potency. This process makes Shoden active even at a low dosage, the company claims.

Arjuna is supporting several ongoing clinical studies of Shoden that it says already have yielded promising results of the ingredient for alleviating depression, stress, and sleep disturbances, and for improving immunomodulation and production of testosterone.